TARS earnings: a positive outcome, +18.3%

On February 27, 2024, Tarsus Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +18.3% in the window around the event. It had already run +22.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.